Back
  1. Home
  3. Detailled Reference
Request a copy
Poster (Scientific congresses and symposiums)
Long term real-world effectiveness and safety of upadacitinib in patients with moderate to severe Crohn's disease: A Belgian multi-centric refractory cohort
Pavlidi, Anastasia; Verstockt, Bram; Vieujean, Sophie et al.
2025 • European Crohn's and Colitis Organisation 2025
Peer reviewed
Permalink
https://hdl.handle.net/2268/326129
 

Files (1)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
DORES_FINAL.docx
Author preprint (26.63 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to


Details


Disciplines :
Gastroenterology & hepatology
Author, co-author :
Pavlidi, Anastasia
Verstockt, Bram
Vieujean, Sophie  ;  Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie ; Université de Liège - ULiège > GIGA ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Desmedt, Valerie
Couturier, Filip
Rahier, Jean-Francois
Baert, Filip
Somers, Michael
Dewit, Olivier
Bossuyt, Peter
Hoyois, Alice
Holvoet, Tom
Ouziel, Romy
Willandt, Barbara
Lambrecht, Guy
Salame, Mika
Verreth, Annelies
Lenfant, Matthias
Franchimont, Denis
Cremer, Anneline
More authors (10 more) Less
Language :
English
Title :
Long term real-world effectiveness and safety of upadacitinib in patients with moderate to severe Crohn's disease: A Belgian multi-centric refractory cohort
Publication date :
21 February 2025
Event name :
European Crohn's and Colitis Organisation 2025
Event place :
Berlin, Germany
Event date :
February 12-14, 2025
By request :
Yes
Audience :
International
Peer reviewed :
Peer reviewed
Available on ORBi :
since 04 January 2025

Statistics

Number of views
8 (0 by ULiège)
Number of downloads
0 (0 by ULiège)
More statistics

Bibliography

Similar publications


Contact ORBi